The stock of Emerald Health Therapeutics Inc (CVE:EMH) is a huge mover today! About 103,528 shares traded hands. Emerald Health Therapeutics Inc (CVE:EMH) has risen 6.00% since October 4, 2016 and is uptrending. It has outperformed by 4.79% the S&P500.
The move comes after 6 months negative chart setup for the $46.83M company. It was reported on Nov, 3 by Barchart.com. We have $0.67 PT which if reached, will make CVE:EMH worth $6.09M less.
More recent Emerald Health Therapeutics Inc (CVE:EMH) news were published by: Marketwatch.com which released: “Emerald Health Therapeutics Completes Private Placement and Shares for Debt …” on September 21, 2016. Also Stockhouse.com published the news titled: “T-Bird Pharma Inc. Announces Name Change to Emerald Health Therapeutics Inc.” on June 19, 2015. Bloomberg.com‘s news article titled: “Stemcentrx Sale to Return a Record $1.7 Billion for VC Firm Founders Fund” with publication date: April 28, 2016 was also an interesting one.
Emerald Health Therapeutics, Inc., formerly T-Bird Pharma Inc., is a Canada company, which through its subsidiary, Emerald Health Botanicals Inc. , is engaged in the production and sale of medical marihuana. The company has a market cap of $46.83 million. The Company’s segment is production and sales of medical marihuana pursuant to the Marihuana for Medical Purposes Regulations. It currently has negative earnings. Botanicals produces cannabis oils and capsules.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.